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Abstract
Objective: To assess the impact of the National Essential Medicines Scheme (NEMS) with respect to urban-rural
inequalities regarding drug prescriptions in primary care facilities.
Methods: A stratified two-stage random sampling strategy was used to sample 23,040 prescriptions from 192
primary care facilities from 2009 to 2010. Difference-in-Difference (DID) analyses were performed to test the
association between NEMS and urban-rural gaps in prescription patterns. Between-Group Variance and Theil Index
were calculated to measure urban-rural absolute and relative disparities in drug prescriptions.
Results: The use of the Essential Medicines List (EML) achieved a compliance rate of up to 90 % in both urban and
rural facilities. An overall reduction of average prescription cost improved economic access to drugs for patients in
both areas. However, we observed an increased urban-rural disparity in average expenditure per prescription. The
rate of antibiotics and glucocorticoids prescription remained high, despite a reduced disparity between urban and
rural facilities. The average incidence of antibiotic prescription increased slightly in urban facilities (62 to 63 %) and
reduced in rural facilities (67 % to 66 %). The urban-rural disparity in the use of parenteral administration (injections
and infusions) increased, albeit at a high level in both areas (44 %-52 %).
Conclusion: NEMS interventions are effective in reducing the overall average prescription costs. Despite the
increased use of the EML, indicator performances with respect to rational drug prescribing and use remain poor
and exceed the WHO/INRUD recommended cutoff values and worldwide benchmarks. There is an increased gap
between urban and rural areas in the use of parenteral administration and expenditure per prescription.
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Introduction
The World Health Organization (WHO) defines the ra-
tional use of drugs as “patients receiving medications ap-
propriate to their clinical needs, in doses that meet their
own individual requirements, for an adequate period of
time, and at the lowest cost to them and their commu-
nity” [1, 2]. Rational use suggests that drugs should only
be used in relation to the right diagnosis and right treat-
ment: administered in appropriate strength, dosage,
frequency, duration, and route of administration that is
most convenient to the patient, with the best possible
outcome and the least possible risk of adverse outcomes
[1, 3]. Rational use is predicated upon a reliable diagno-
sis based on the correct identification of a patient’s pre-
senting signs and symptoms; consideration of potential
management options (both drug and non-drug related);
determination of appropriate drugs, dosage and dur-
ation; prescription; administration; and monitoring of ef-
fect with adjustment of treatment options as and when
required [4].
Rational drug prescribing contributes to global reduc-
tions in population morbidity and mortality with
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consequential medical, social and economic benefits [5].
Unfortunately, the irrational use of drugs is endemic, es-
pecially in middle and low income countries [6, 7]. Com-
mon aspects of irrational drug use include misuse,
overprescribing or poly-pharmacy (prescribing more spe-
cies of drugs than strictly necessary), inadequate dosage,
and inadequate duration of drug therapy [1, 3]. In 2010,
the WHO reported that, more often than not, drugs are
prescribed inappropriately, compounded by 50 % of all pa-
tients using their medicines incorrectly [8]. The misuse
and overuse of antibiotics is a serious concern in China
[9–11]. The frequency of antibiotic prescriptions in China
is twice that of the indicator developed by the WHO. Pa-
tients in China are three times more likely to have pre-
scriptions requiring administration by infusion and
injections than those from similar countries [12].
There is a wide disparity in the rational use of drugs
between high-income and low- and middle-income
countries. The overuse of parenteral administration is
particularly prevalent in low-income countries, alarm-
ingly so when many cannot guarantee safety of this route
of administration [9, 13]. The WHO reported that about
90 % of parenteral administrations are unnecessary as
there are better routes available [12]. In China, similar
gaps between urban (richer) and rural (poorer) areas
exist. Dong, Yan, and Wang found that the overuse of
antibiotics and parenteral administration (i.e. infusions
and injections) in preference to the oral route are the
most prominent manifestations of irrational drug pre-
scription practices in rural areas of Western China [14].
Chen et al found that antibiotics prescribed without any
indication of infection for adult patients during routine
outpatient consultations in Shandong and Gansu prov-
inces ranged from 34 to 77 %, and parenteral adminis-
tration of antibiotics in those patients ranged from 22 to
61 % [15].
Many countries have developed and implemented strat-
egies or policies to improve the rational drug use [16].
China developed a comprehensive National Essential
Medicines Scheme (NEMS) in 2009, with an aim to con-
trol growth of drug expenditure and improve quality use
of medicines [17]. The 2009 NEMS contains a list of 317
drugs that must be accessible by primary care providers
for the benefit of consumers. In acknowledgement of the
importance of this initiative it was nominated as one of
the five priorities in healthcare reform strategy (2009–11)
[18, 19]. The Central Government State Council estab-
lished a national target for 30 % coverage of NEMS within
public primary care institutions in 2009, aiming towards
100 % coverage by the end of 2011 [7]. By 2011, somewhat
ahead of the target deadline, the national EML and
province-based centralized-procurement systems for pri-
mary healthcare institutions had been established and
were in use all over China. All public primary care
institutions can only provide essential medicines listed in
EML and all drugs must be directly purchased from accre-
dited suppliers via centralized procurement arrangements.
Despite significant efforts in implementing these strat-
egies, empirical experience to date suggests doubt regard-
ing the effectiveness of the NEMS for achieving its policy
goals. A three year study of the use of antibiotics, hor-
mones, and intravenous parenteral administration in out-
patient services and primary care institutions in 83
counties/cities showed variable and small changes in the
institutions where NEMS had been adopted, compared
with those that had not adopted such schemes [20]. Yang
et al found that while the NEMS interventions in Hubei
province reduced the cost of medicines, the overuse of an-
tibiotics and parenteral administration remained at high
levels [7]. Many contextual factors are believed to contrib-
ute to the failure to fully achieve the NEMS expectations
[10, 12, 14, 15, 21–24].
This study aims to examine the urban-rural inequalities
regarding drug prescriptions in primary care facilities and
the impact of the NEMS on such inequalities. Under-
standing the potential effect of NEMS on possible inequal-
ities in drug prescription practices between urban and
rural primary care facilities is important to inform and
prioritize policy interventions, because changes in use of
medicines may occur more markedly in one particular
subgroup of population than in others. Overall "improved"
averages may also accompany wider disparities between
regions - some regions may even be worse off.
Methods
Setting
This study was conducted in A province. A province is
located in the middle-eastern of China, with a popula-
tion of 56,493,891 (in 2010). The total gross domestic
product (GDP) of the province was CNY¥ 1235.9 billion
(US$ 181.8 billion) in 2010.
Primary care facilities were the principal sources of in-
formation for this study, which focused on urban com-
munity health centers (CHCs) and rural township health
centers (THCs). The Chinese health system is character-
ized by a three tier healthcare delivery system. The
urban three tier system comprises CHCs, district hospi-
tals and municipal/regional hospitals, while the rural
three-tier system comprises village clinics, THCs, and
county hospitals [19, 25]. THCs are the crux of the rural
service network, providing primary care services, med-
ical care services and public health services, in addition
to technical support and training to health workers of
village clinics [26]. While CHCs are the urban counter-
part of THCs, they occupy a foundational status within
the urban three-tier network, although some CHCs may
run outreach stations within communities, which resem-
ble rural village clinics.
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Sampling
Data were collected in 2009 and 2010, samples preced-
ing and following NEMS implementation. We consid-
ered CHCs and THCs in the 32 counties/districts where
the NEMS was introduced on 1 January 2010 eligible for
potential inclusion in the study.
The sample size was determined in accordance with
the guideline of the WHO “How to investigate drug use
in health facilities: selected drug use indicators” [27]. To
assess the impact of interventions, at least 10 facilities
(or 20 for a more reliable study) per group and 30 pre-
scribing encounters per facility were recommended.
Based on 80 % power to detect a significant difference of
p = 0.05, a moderate effect size of 0.02 (2 percentage
points change in prescription rate), 3520 prescriptions
per group pre- or post-interventions were required [28].
The sample size of this study achieved a minimum of
3760 (for urban facilities).
A stratified two-stage random sampling strategy was
used in the study. In the first stage, four urban districts
and nine rural counties were randomly selected. All pub-
lic primary care facilities (n = 192) in the selected dis-
tricts/counties were included in the study (63 from
urban districts, 129 from rural counties). In the second
stage, we used a systematic random sampling method to
collect 120 outpatient prescriptions at each health cen-
ter. These included 20 prescriptions randomly selected
on the 2th March, 6th July and 2th November 2009 re-
spectively (prior to the introduction of NEMS), and 20
prescriptions randomly selected on the 1st March, 5th
July, and 1st November 2010 respectively (after NEMS
implementation on 1st January 2010) for each health
center. The sampling of prescriptions was extended to
the following day if the sample size did not reach 20.
We specifically excluded prescriptions arising from con-
sultations in the departments of emergency, communic-
able diseases and surgery, and those containing traditional
Chinese medicine decoctions.
Data from 23,040 collected prescriptions were trans-
ferred into an electronic data spreadsheet: of these some
67 sampled prescriptions contained conflicting informa-
tion or lacked key information and were therefore ex-
cluded. This resulted in a final sample of 22,973
prescriptions (7519 urban and 15,454 rural) for analysis.
Data analysis
The WHO and International Network for Rational Use
of Drugs (WHO/INRUD) developed a list of indicators
[27, 29] that are widely used for assessing irrational or
inappropriate prescribing [12]. We adapted four of the
five prescribing indicators in this study [27]:
1. average number of drug species per prescription;
2. percentage of prescriptions requiring antibiotics;
3. percentage of prescriptions requiring injections; and
4. percentage of drugs prescribed from the EML.
The WHO/INRUD indicator regarding prescription of
generic drugs was discarded because almost all medicines
prescribed by the primary care facilities in China are
generic medicines.
In response to overwhelming concerns from local
health officials, we added two additional indicators:
5. percentage of prescription requiring glucocorticoids;
and
6. average expenditure per prescription.
For this study, a ‘glucocorticoid’ was defined as a sys-
temic administration of a glucocorticoid (oral or via par-
enteral route) and specifically excluded local or topical
applications [19].
Outcomes in relation to the above indicators were
compared on an annual comparative basis (before and
after introduction of the NEMS) and between urban and
rural facilities. Statistical significances of the comparative
results were examined using Chi-Square tests for the
categorical indicators (frequencies) and student t-tests or
Analysis of Variance (ANOVA) for the continuous mea-
surements (quantity and drug expenditure).
We adopted the difference-in-difference (DID) method
to assess the impact of the NEMS on urban-rural in-
equalities regarding the prescription indicators, control-
ling for the characteristics of facilities (servicing radius,
population and density, number and composition of
staff, income of staff and organizations) and community
profiles (age, sex, marriage, and income).
We used a logistic regression method (eq 1) for cat-
egorical indicators (such as indicator 1, 2, 3, and 4) and
least squares regression model (eq 2) for continuous in-























Where, i =1 . . . i prescription, j =1. . . j organization;
pij represents the probability of the occurrence of a pre-
scribing behavior (i.e., 1 yes or 0 no); Tij indicates when
the prescription was made (0 pre-NEMS or 1 post-
NEMS); Aij represents the setting in which the prescrip-
tion was made (0 urban or 1 rural); p =1. . . p
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community covariate, o =1. . .o organization covariate;
xoij and xpij are control variables. Coefficient β3 repre-
sents the DID coefficient and reflects the effect of the
NEMS on urban-rural differences in the prescribing
indicators.
Between-Group Variance (BGV) [30, 31] and Theil
Index (TI) [32, 33] were calculated to measure urban-
rural absolute inequality and relative inequality, respect-
ively. A higher value of BGV and TI indicates a higher







where pj represents group j’s population size, yj repre-
sents group j’s average status, and u represents the aver-





where pj represents the proportion of population of
group j in total and rj represents the ratio of a condition
in group j relative to the total [35].
The analyses were performed using Stata software ver-
sion 13.0 [36] and Health Disparities Calculator version
1.2.4 [37].
This study was approved by the Ethical Review Com-
mittee of Tongji Medical College, Huazhong University
of Science and Technology (IORG No: IORG0003571).
Results
Characteristics of participating primary health centers
The magnitudes of client populations and geographic
areas are often considered defining differences: a higher
client population density was shown in urban facilities
compared with their rural counterparts (p < 0.001).
Urban primary care facilities in this study served an area
ranging on average from 270 to 491 km2, whereas rural
areas were far larger from 470 to 763 km2. Urban facil-
ities also had more staff (p < 0.05) and doctors (p < 0.01),
and higher levels of annual revenue (p < 0.05) and salaries
for medical staff (p < 0.001) than rural facilities. Despite
this, the average revenue generated from drug prescrip-
tions was slightly higher in rural facilities (CNY¥
1,149,600) compared to urban facilities (CNY¥ 1,122,600),
but without statistical significance (p = 0.256).
Both urban and rural facilities had at least 166 spe-
cies of drugs from the EML. Urban primary care facil-
ities had a greater range of drugs both from within
and in addition to the EML than their rural counter-
parts. National EML drugs contributed to a similar
proportion (57 %-60 %) in the complete range of drugs
available (Table 1).Bold indicates statistical signifi-
cance (p < 0.05)
Urban-rural inequalities in prescribing indicators
Urban-rural inequalities existed prior to the NEMS
(Table 2): primary care providers in rural facilities pre-
scribed more varieties of drugs per prescription (p < 0.001)
and were more likely to prescribe antibiotics (p < 0.01)
and drugs from the EML (p < 0.001). But no significant
urban-rural differences in glucocorticoids prescription,
parenteral administration of drugs, and average cost per
prescription were found (p > 0.05). The average prescrip-
tion price to the consumer was about CNY¥ 42 (about
US$6 in 2009) for both urban and rural patients.
The DID tests demonstrated significant effects of NEMS
on urban-rural differences (p < 0.05) in the use of antibi-
otics and EML, and prescription costs (Table 2). The pre-
existing urban-rural disparity in prescriptions containing
antibiotics declined, due to a slight decrease in urban and
a corresponding increase in rural facilities. The proportion
of prescriptions from the EML reached a consistent high
level of nearly 90 % in both urban and rural facilities.
However, significant urban-rural gaps in prescription costs
appeared after NEMS implementation. Despite a signifi-
cant decline in expenditure associated with the prescrip-
tions in both groups, rural facilities were more likely to
order and prescribe more expensive drugs (p < 0.001)
compared with their urban counterparts.
The emerging urban-rural difference in the use of par-
enteral administration of drugs (p < 0.01) post NEMS
was found to be associated with controlling/confounding
factors, not the NEMS itself (p = 0.329).
Absolute and relative urban-rural inequalities
Mixed trends of area-based absolute inequality (Table 3)
and relative inequality (Table 4) in drug prescription
practices were found. Urban-rural absolute and relative
disparities in the use of antibiotics (p < 0.05) and pre-
scriptions from the EML (p < 0.05) decreased. Progress
was also demonstrated in eliminating relative inequality
in the proportion of prescriptions requiring glucocorti-
coids (p < 0.01); however, the absolute and relative
inequality in prescription cost increased (p < 0.001). Dis-
parities in the average number of drugs per prescription
remained constant (p > 0.1).
Relative measures are without units and could be used
to compare the inequality of indicators with different
units [34]. As shown in Table 4, it is clear that the rela-
tive inequality of average number of drug per prescrip-
tion is at a much higher level than that of other
indicators both in 2009 and 2010. Meanwhile, increased
and higher levels of relative inequality were also found
in 2010 regarding prescriptions requiring injections and
average expenditure per prescription.
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Absolute and relative inequality measures are usually
reported together for relative indicators could be used to
make comparisons between indicators with different
units and absolute indicators reflect the concrete differ-
ence value between subgroups [34]. Fig. 1 demonstrates
that increasing urban-rural absolute and relative inequal-
ities is evident for parenteral administration and pre-
scription expenditure. A consistently high level of
urban-rural relative inequality was observed for the
“number of drugs per prescription”.
By using “average improving of indicators” and “changes
of relative inequality”, all indicators were placed into a
four-quadrant view (Fig. 2). The upper left group (a) in-
dicates improvement in both average levels and equal-
ities of indicators. The proportion of drugs prescribed
from the EML fell into this group. The lower left group
(b) reflects improved urban-rural equality but with lim-
ited changes in average levels. Attention should be paid
to the improvement of the levels of those indicators,
such as the proportion of prescriptions requiring anti-
biotics or glucocorticoids. The upper right group (c) in-
dicates improvement in average levels but with
enlarged inequalities of indicators. Average expenditure
per prescription fell into this group. The lower right
group (d) represents the worst performed indicators in
both average levels and equalities. Prescriptions requir-
ing injections fell into this group. The final group (e)
stands in the middle, indicating limited changes in both
average levels and inequalities. The average number of
drugs per prescription fell into this group.
Discussion
This study assesses the impact of the NEMS on urban-
rural inequalities regarding drug prescriptions in primary
care facilities, and we found a mixed picture.
The most prominent achievement is the compliance
with the EML. Both urban and rural facilities have in-
creased their use of EML, reaching a compliance rate of
about 90 %. The former urban-rural disparity for this in-
dicator is no longer present. Our results indicate that
proportion of drugs prescribed from the EML increased
from 66.71 to 88.28 % in urban areas and from 75.40 to
92.30 % in rural areas, a performance outcome higher
than Western Pacific countries (75.5 %), South East Asia
(77.0 %), and lower-middle income countries (81.7 %).
These results agree well with the findings of Yang LP, et
Table 1 Characteristics of participating primary care facilities in urban and rural areas
Indicator Urban (95 % CI) Rural (95 % CI) p value
Client population (thousand) 46.97 (42.66, 51.29) 43.49 (39.00, 47.99) 0.014
Serving radius (km) 10.88 (9.27, 12.50) 13.91 (12.23, 15.58) 0.013
Population density (people/km2) 1036.15 (474.33, 1597.97) 248.01 (203.08, 292.94) 0.000
Number of medical staff 43.38 (38.53, 48.24) 41.30 (36.46, 46.15) 0.013
Number of doctor 17.69 (15.18, 20.20) 13.83 (12.32, 15.34) 0.001
Monthly income of medical staff (yuan) 2161.68 (2041.10, 2282.26) 1812.13 (1737.93, 1886.33) 0.000
Annual income of facility (thousand yuan) 3729.41 (3235.44, 4223.38) 3185.05 (2864.58, 3505.52) 0.020
Drug income of facility (thousand yuan) 1122.60 (896.87, 1348.34) 1149.62 (1009.00, 1290.24) 0.256
Variety of drugs in stock 324.13 (292.18, 356.08) 294.30 (276.33, 312.26) 0.753
Variety of drugs from national EMLs 183.98 (166.22, 201.74) 175.98 (166.00, 185.96) 0.366
Bold indicates statistical significance (p < 0.05)
Table 2 Prescribing indicators in primary care facilities in A province of China - pre and post NEMS
Indicator Urban (95 % CI) Rural (95 % CI) Urban-rural difference NEMS effect
Pre Post Pre Post Adjusted beta (95 % CI) p value Pre p value Post p value
Average number of drugs per prescription 3.61 3.45 4.33 4.15 -0.079 (-0.230, 0.073) 0.311 0.000 0.000
Percentage of prescriptions with
antibiotics prescribed (%)
61.63 62.51 67.26 66.05 -0.154 (-0.286, -0.021) 0.023 0.009 0.152
Percentage of prescriptions with
glucocorticoids prescribed (%)
19.97 19.37 23.99 22.1 -0.135 (-0.296, 0.026) 0.101 0.081 0.428
Percentage of prescriptions with
injections prescribed (%)
44.95 44.04 51.07 52.35 0.006 (-0.127, 0.139) 0.329 0.237 0.003
Percentage of drugs prescribed from
the essential drug list (%)
66.71 88.28 75.4 92.3 -0.298 (-0.572, -0.025) 0.032 0.000 0.412
Average expenditure per prescription (yuan) 42.12 28.2 42.74 32.73 2.869 (0.450, 5.289) 0.020 0.856 0.000
Bold indicates statistical significance (p < 0.05)
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al [7]. We suspect limited choices and availability of
medicines contributes to this effect: NEMS specifies that
pharmaceutical supply in primary care facilities are re-
stricted to only those drugs listed in the EML.
Another important achievement is the reduction of ex-
penditure per prescription, which may be a result of a
proportional increase of EML drugs and reduction of
drug stocks; this finding is consistent with earlier find-
ings [7, 38]. The four elements of NEMS may contribute
to the overall reduction of prescription expenditure, in-
cluding EML, province-based centralized procurement
initiatives, zero-mark-up policy, and reimbursement ar-
rangements for EML drugs. All drugs on the NEMS list
are subject to the zero-mark-up policy, and EML drugs
usually have a higher reimbursement rates.
Overall, NEMS improved the economic access of
drugs in both rural and urban areas in the province in-
vestigated; however, it appears that benefits are not
equally distributed. Urban residents enjoy a greater cost
reduction than their rural counterparts. One possible
reason for this could be the differences in medical insur-
ance between urban and rural areas. The reimbursement
ratio of Urban Employee Basic Medical Insurance is
higher than that of New Cooperative Medical Scheme in
rural areas. Moreover, drug supply logistics are challen-
ging in remote and rural areas due to higher distribution
costs. As a result, urban primary care facilities are able
to pass on a higher level of benefits onto their patients
than their rural counterparts.
The urban-rural gap in the use of antibiotics and gluco-
corticoids closed; however, antibiotic use in urban areas
showed no reduction. It is a challenge to estimate the
seriousness of irrational use of drugs from the prescribing
indicators without proper risk-adjustment: we note the
role of the WHO in establishing benchmarks. The WHO/
INRUD suggests an indicator of optimal incidence of anti-
biotic prescriptions at less than 30 % of all prescriptions
[14]. Currently, the percentage of prescriptions containing
antibiotics (62.51 % urban, 66.05 % rural) exceeds these
benchmarks (Table 5) [14, 39].
Unexpectedly, the urban-rural gap in the use of in-
jections increased with little decline in urban area
and even worse in rural area. Meanwhile, the overall
incidence of parenteral administration (44.04 % urban,
52.35 % rural) remains much higher than the WHO
optimal value (<10 %) [14]. This finding is similar to
the previous studies of Yang LP et al [7] and Li Y
et al [38]. This study suggests that the NEMS is not
associated with the increased urban-rural disparity in
unnecessary parenteral administration. Indeed, both
doctors and patients may play a role for the overuse
of drug administration via injections or infusions.
Doctors in urban areas usually have relatively higher
levels of education and medical training, which ap-
pears to be associated with lower levels of non-oral
administration than others [21]. In China, most pa-
tients, especially in rural areas, believe that infusions
and injections are more efficacious than oral medi-
cines, which in turn exerts an ethical dilemma for
doctors who might otherwise recommend the oral
route [24].
Finally, the urban-rural disparity in the average num-
ber of drugs per prescription remains unchanged. The
average number of drugs prescribed, especially in rural
Table 3 Area-based Between-Group Variance (BGV) for drug prescription indicators - pre and post NEMS
Indicator Pre (95 % CI) Post (95 % CI) p value
Average number of drugs per prescription 0.113 (0.083, 0.143) 0.106 (0.079, 0.133) 0.746
Percentage of prescriptions requiring antibiotics (%) 6.979 (2.300, 11.658) 2.764 (-0.212, 5.739) 0.024
Percentage of prescriptions requiring glucocorticoids (%) 3.558 (0.709, 6.408) 1.638 (-0.283, 3.559) 0.206
Percentage of prescriptions requiring injections (%) 8.236 (2.972, 13.500) 15.163 (8.053, 22.273) 0.668
Percentage of drugs prescribed from the essential drug list (%) 16.656 (10.502, 22.811) 3.551 (1.083, 6.018) 0.037
Average expenditure per prescription 0.085 (-0.651, 0.821) 4.52 (2.182, 6.859) 0.000
Bold indicates statistical significance (p < 0.05)
Table 4 Area-based Theil Index (×10000) for drug prescription indicators - pre and post NEMS
Indicator Pre (95 % CI) Post (95 % CI) P value
Average number of drugs per prescription 34.517 (25.355, 43.678) 35.208 (26.052, 44.365) 0.171
Percentage of prescriptions requiring antibiotics 8.239 (2.714, 13.765) 3.303 (-0.204, 6.810) 0.005
Percentage of prescriptions requiring glucocorticoids 35.392 (7.047, 63.736) 18.499 (-2.897, 39.894) 0.005
Percentage of prescriptions requiring injections 17.367 (6.236, 28.499) 31.421 (16.536, 46.306) 0.246
Percentage of drugs prescribed from the essential drug list 16.052 (10.148, 21.957) 2.156 (0.675, 3.636) 0.040
Average expenditure per prescription 0.235 (-1.160, 1.631) 23.564 (11.289, 35.840) 0.001
Bold indicates statistical significance (p < 0.05)
Yao et al. International Journal for Equity in Health  (2015) 14:58 Page 6 of 9
areas, remains high compared to Western Pacific (2.8),
South East Asia (2.4), and lower-middle income coun-
tries (2.8), and far from the WHO/INRUD recom-
mended value: 1.6-2.8 [39, 40].
Conclusion
This study shows that the NEMS interventions reduced
overall average patient expenditure and increased the
use of EML drugs by prescribers. But the cost benefits
are not equally distributed: urban patients enjoy a
Fig. 1 Area-based inequality trends. Changes of area-based inequality regarding drug prescription indicators, 2009-2010
Fig. 2 Four-quadrant view: improving of indicators vs urban-rural
inequality. Four-quadrant view of drug prescription indicators:
improving of indicators versus urban-rural inequality, 2009-2010.
Group (a): I5 - Percentage of drugs prescribed from the essential
drug list, shows improvement in both average level and equality;
Group (b): I2 - Percentage of prescriptions requiring antibiotics,
I3 - Percentage of prescriptions requiring glucocorticoids: these -
indicators show improved urbanrural equality but with limited changes
in average levels Group (c): I6 - Average expenditure per prescription,
shows improvement in average level but with enlarged inequality;
Group (d): I4 - Percentage of prescriptions requiring injections, shows
poor performance in both average level and equality; Group
(e): I1 - Average number of drugs per prescription, shows little
changes in both average level and equality
Table 5 Prescribing indicators in comparison with other
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Yao et al. International Journal for Equity in Health  (2015) 14:58 Page 7 of 9
greater cost reduction than their rural counterparts. Im-
provements in other indicators are absent. Prescription
rates associated with antibiotics and glucocorticoids re-
main high despite reductions in urban-rural disparities.
Both urban and rural practices exceed WHO/INRUD
recommended cutoff values and worldwide benchmarks.
The rate of parenteral drug administration in both urban
and rural areas remains high compared with the WHO
benchmarks.
The effectiveness of the NEMS is dependent upon
multi-faceted strategies including education, manager-
ial and financial interventions, and regulatory policies.
Educational strategies targeted towards prescribers
include standard treatment guidelines, flow charts,
newsletters, bulletins and printed information (such
as leaflets) [39, 41–43]. Managerial strategies include
EML, kit system distribution, pre-printed order forms,
stock control, course-of-therapy packaging, and effect-
ive package labeling [44, 45]. Regulatory strategies in-
volve, for example, banning unsafe drugs, and limiting
the import of drugs on the domestic market [44, 45].
However, the effectiveness of current financial incen-
tives and interventions remains uncertain and prob-
lematic [44]. Unfortunately, Chinese township health
centers lack a sustainable and developmental financial
compensation mechanism for NEMS. As a result,
many highly qualified health workers are leaving their
institutions and some are departing medical practice.
It would seem reasonable that a long-term compensa-
tion mechanism must be considered [7].
Limitations
This study attempts to examine the impact of the NEMS
on inequalities in quality use of medicines between
urban and rural primary care facilities in China. The
characteristics of health organizations and community
profiles were controlled for potential confounding ef-
fects; however, due to limited availability of data we were
unable to control the potential confounding effect of the
characteristics of prescribers, such as their age, educa-
tion and working experiences. This study was under-
taken in one region of China: further studies are needed
to assess inequality among different regions.
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